• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血磷脂酸对肿瘤免疫的调节作用

Regulation of Tumor Immunity by Lysophosphatidic Acid.

作者信息

Lee Sue Chin, Dacheux Mélanie A, Norman Derek D, Balázs Louisa, Torres Raul M, Augelli-Szafran Corinne E, Tigyi Gábor J

机构信息

Department of Physiology, University of Tennessee Health Science Center; Memphis, TN 38163, USA.

Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center; Memphis, TN 38163, USA.

出版信息

Cancers (Basel). 2020 May 10;12(5):1202. doi: 10.3390/cancers12051202.

DOI:10.3390/cancers12051202
PMID:32397679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7281403/
Abstract

The tumor microenvironment (TME) may be best conceptualized as an ecosystem comprised of cancer cells interacting with a multitude of stromal components such as the extracellular matrix (ECM), blood and lymphatic networks, fibroblasts, adipocytes, and cells of the immune system. At the center of this crosstalk between cancer cells and their TME is the bioactive lipid lysophosphatidic acid (LPA). High levels of LPA and the enzyme generating it, termed autotaxin (ATX), are present in many cancers. It is also well documented that LPA drives tumor progression by promoting angiogenesis, proliferation, survival, invasion and metastasis. One of the hallmarks of cancer is the ability to modulate and escape immune detection and eradication. Despite the profound role of LPA in regulating immune functions and inflammation, its role in the context of tumor immunity has not received much attention until recently where emerging studies highlight that this signaling axis may be a means that cancer cells adopt to evade immune detection and eradication. The present review aims to look at the immunomodulatory actions of LPA in baseline immunity to provide a broad understanding of the subject with a special emphasis on LPA and cancer immunity, highlighting the latest progress in this area of research.

摘要

肿瘤微环境(TME)或许可以被最好地概念化为一个生态系统,该系统由癌细胞与多种基质成分相互作用构成,这些基质成分包括细胞外基质(ECM)、血液和淋巴网络、成纤维细胞、脂肪细胞以及免疫系统细胞。癌细胞与其TME之间这种相互作用的核心是生物活性脂质溶血磷脂酸(LPA)。许多癌症中都存在高水平的LPA及其生成酶——自分泌运动因子(ATX)。同样有充分文献记载,LPA通过促进血管生成、增殖、存活、侵袭和转移来推动肿瘤进展。癌症的一个标志是能够调节并逃避免疫检测和清除。尽管LPA在调节免疫功能和炎症方面具有重要作用,但直到最近,其在肿瘤免疫背景下的作用才受到较多关注,新出现的研究强调这个信号轴可能是癌细胞用来逃避免疫检测和清除的一种方式。本综述旨在探讨LPA在基础免疫中的免疫调节作用,以全面了解该主题,特别强调LPA与癌症免疫,突出这一研究领域的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7281403/6f598902b7cb/cancers-12-01202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7281403/d8b62304e0e8/cancers-12-01202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7281403/bc4ea24338df/cancers-12-01202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7281403/6f598902b7cb/cancers-12-01202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7281403/d8b62304e0e8/cancers-12-01202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7281403/bc4ea24338df/cancers-12-01202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7281403/6f598902b7cb/cancers-12-01202-g003.jpg

相似文献

1
Regulation of Tumor Immunity by Lysophosphatidic Acid.溶血磷脂酸对肿瘤免疫的调节作用
Cancers (Basel). 2020 May 10;12(5):1202. doi: 10.3390/cancers12051202.
2
Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.自分泌运动因子-溶血磷脂酸受体轴对肿瘤细胞-微环境相互作用的调控
Adv Biol Regul. 2019 Jan;71:183-193. doi: 10.1016/j.jbior.2018.09.008. Epub 2018 Sep 16.
3
Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?溶血磷脂酸:促进癌症进展和肿瘤微环境发展。是否有望成为抗癌治疗的新靶点?
Cells. 2021 Jun 4;10(6):1390. doi: 10.3390/cells10061390.
4
Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid.鞘脂类和溶血磷脂酸调控肿瘤免疫微环境。
Curr Drug Targets. 2022;23(6):559-573. doi: 10.2174/1389450122666211208111833.
5
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.自分泌运动因子-溶血磷脂酸-溶血磷脂酸受体级联反应:一种治疗多形性胶质母细胞瘤新潜在治疗靶点的提议
Lipids Health Dis. 2015 Jun 18;14:56. doi: 10.1186/s12944-015-0059-5.
6
Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression.胰腺导管腺癌肿瘤微环境中自分泌运动因子和溶血磷脂酸介导信号传导的研究进展:通路基因表达调查
Am J Cancer Res. 2024 Aug 25;14(8):4004-4027. doi: 10.62347/KQNW1871. eCollection 2024.
7
New insights into the autotaxin/LPA axis in cancer development and metastasis.对自分泌运动因子/溶血磷脂酸轴在癌症发生和转移中的新见解。
Exp Cell Res. 2015 May 1;333(2):183-189. doi: 10.1016/j.yexcr.2014.11.010. Epub 2014 Nov 25.
8
ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.ADSCs 和脂肪细胞是乳腺癌和健康乳腺组织中自分泌酶-溶血磷脂酸轴的主要产生者。
BMC Cancer. 2018 Dec 19;18(1):1273. doi: 10.1186/s12885-018-5166-z.
9
Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.溶血磷脂酸调节 CD8 T 细胞免疫监视和代谢,从而损害抗肿瘤免疫。
Nat Commun. 2023 Jun 3;14(1):3214. doi: 10.1038/s41467-023-38933-4.
10
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.卵巢癌微环境中溶血磷脂酸生物合成和信号转导的细胞类型选择性途径和临床关联。
Mol Oncol. 2019 Feb;13(2):185-201. doi: 10.1002/1878-0261.12396. Epub 2018 Nov 15.

引用本文的文献

1
Identification and validation of prognostic models and tumor microenvironment infiltration characteristics for tRNA modification regulators in clear cell renal cell carcinoma.透明细胞肾细胞癌中tRNA修饰调节因子的预后模型鉴定与验证及肿瘤微环境浸润特征
Oncol Lett. 2025 May 22;30(1):362. doi: 10.3892/ol.2025.15108. eCollection 2025 Jul.
2
Deleting autotaxin in LysM+ myeloid cells impairs innate tumor immunity in models of metastatic melanoma.在LysM+髓样细胞中删除自分泌运动因子会损害转移性黑色素瘤模型中的先天性肿瘤免疫。
iScience. 2024 Sep 17;27(10):110971. doi: 10.1016/j.isci.2024.110971. eCollection 2024 Oct 18.
3

本文引用的文献

1
The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages.结直肠癌细胞中的 Agpat4/LPA 轴通过巨噬细胞中的 p38/p65 信号调节抗肿瘤反应。
Signal Transduct Target Ther. 2020 Mar 27;5(1):24. doi: 10.1038/s41392-020-0117-y.
2
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.当前靶向肿瘤相关巨噬细胞以改善抗肿瘤免疫反应的策略。
Cells. 2019 Dec 23;9(1):46. doi: 10.3390/cells9010046.
3
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy.
Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression.
胰腺导管腺癌肿瘤微环境中自分泌运动因子和溶血磷脂酸介导信号传导的研究进展:通路基因表达调查
Am J Cancer Res. 2024 Aug 25;14(8):4004-4027. doi: 10.62347/KQNW1871. eCollection 2024.
4
Lysophospholipid receptors in neurodegeneration and neuroprotection.神经退行性变和神经保护中的溶血磷脂受体
Explor Neuroprotective Ther. 2024;4(4):349-365. doi: 10.37349/ent.2024.00088. Epub 2024 Aug 22.
5
LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10.溶血磷脂酸抑制人黑色素瘤细胞中HLA - DR的表达:一种涉及LPAR1和DR6介导的IL - 10释放的潜在免疫逃逸机制。
Acta Pharmacol Sin. 2025 Jan;46(1):222-230. doi: 10.1038/s41401-024-01373-x. Epub 2024 Aug 26.
6
Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker.胃癌中脂质代谢与免疫浸润特征之间的相关性进展以及将BCHE鉴定为潜在生物标志物
Front Immunol. 2024 Jan 31;15:1327565. doi: 10.3389/fimmu.2024.1327565. eCollection 2024.
7
A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer.联合靶向抑制 p110δ PI3K 和 RhoA 可消除皮肤癌。
Commun Biol. 2024 Jan 5;7(1):26. doi: 10.1038/s42003-023-05639-8.
8
E2F7 drives autotaxin/Enpp2 transcription via chromosome looping: Repression by p53 in murine but not in human carcinomas.E2F7 通过染色体环化驱动自分泌酶/Enpp2 的转录:p53 在鼠源而非人源肿瘤中抑制其表达。
FASEB J. 2023 Jul;37(7):e23058. doi: 10.1096/fj.202300838R.
9
Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.溶血磷脂酸调节 CD8 T 细胞免疫监视和代谢,从而损害抗肿瘤免疫。
Nat Commun. 2023 Jun 3;14(1):3214. doi: 10.1038/s41467-023-38933-4.
10
Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.细胞外溶血磷脂酸对 CD8 T 细胞信号转导、代谢和细胞毒性活性的调节。
Immunol Rev. 2023 Aug;317(1):203-222. doi: 10.1111/imr.13208. Epub 2023 Apr 25.
肿瘤相关中性粒细胞。它们在肿瘤发生、转移、预后及治疗中的作用
Front Oncol. 2019 Nov 15;9:1146. doi: 10.3389/fonc.2019.01146. eCollection 2019.
4
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.靶向癌症中的溶血磷脂酸:从实验室到临床面临的问题。
Cancers (Basel). 2019 Oct 10;11(10):1523. doi: 10.3390/cancers11101523.
5
Neutrophil Heterogeneity in Cancer: From Biology to Therapies.中性粒细胞异质性在癌症中的作用:从生物学到治疗策略。
Front Immunol. 2019 Sep 20;10:2155. doi: 10.3389/fimmu.2019.02155. eCollection 2019.
6
LPA Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling.LPA 是一种抑制性受体,通过破坏早期 TCR 信号转导来抑制 CD8+T 细胞的细胞毒性功能。
Front Immunol. 2019 May 28;10:1159. doi: 10.3389/fimmu.2019.01159. eCollection 2019.
7
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.评估有资格接受和对检查点抑制剂免疫治疗药物有反应的美国癌症患者的百分比。
JAMA Netw Open. 2019 May 3;2(5):e192535. doi: 10.1001/jamanetworkopen.2019.2535.
8
Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer.卵巢癌中鞘脂和溶血磷脂酸信号与免疫系统的相互关系
Comput Struct Biotechnol J. 2019 Apr 10;17:537-560. doi: 10.1016/j.csbj.2019.04.004. eCollection 2019.
9
Expression of Autotaxin⁻Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma.脂肪基质乳腺癌中 Autotaxin-溶血磷脂酸信号相关蛋白的表达。
Int J Mol Sci. 2019 Apr 29;20(9):2102. doi: 10.3390/ijms20092102.
10
Macrophages as regulators of tumour immunity and immunotherapy.巨噬细胞作为肿瘤免疫和免疫治疗的调节剂。
Nat Rev Immunol. 2019 Jun;19(6):369-382. doi: 10.1038/s41577-019-0127-6.